Previous 10 | Next 10 |
2023-04-10 15:36:01 ET Deutsche Bank raised its recommendation for contract manufacturer Catalent ( NYSE: CTLT ) to Buy from Hold and lifted its price target to $88 from $79 per share, citing a potential upside to the company's 2023/ 2024 estimates. "The crux of our upgrade is t...
2023-03-20 09:28:59 ET Summary Catalent’s COVID-19 related revenues have fallen, but cushioned by growth in other areas and they continue to expand their activities. A lawsuit over accusations of misleading investors is ongoing that could grow to be a headache. After a ...
New York, New York--(Newsfile Corp. - March 13, 2023) - Levi & Korsinsky, LLP notifies investors in Catalent, Inc. ("Catalent" or the "Company") (NYSE: CTLT) of a class action securities lawsuit. The lawsuit on behalf of Catalent investors has been commenced in the the United States Distri...
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that members of its executive leadership team will participate at two upcoming investor conferences. On March 14, 2023 at 10:45 a.m. ET, the Company will...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Catalent To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 8, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is i...
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Sridhar Krishnan, to the newly created position of Vice President, The Catalent Way, where he will lead the company’s operational e...
2023-03-05 05:11:06 ET Summary Danaher has benefited from the Covid-19 period. The company has seen strong (earnings) growth, and it's positioned to maintain this. Interesting deals have been pursued and leverage is very reasonable. Appeal is luring here at a 22-23 times e...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Catalent To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 3, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Catalent To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 2, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is i...
The S&P 500 ( SP500 ) slid nearly 3% for February, final figures showed on Tuesday, eating into the solid gains it had made in the first month of the new year. Sentiment was weighed down by hotter-than-expected inflation data and concerns over the Federal Reserve's rate hikes. Losses ...
News, Short Squeeze, Breakout and More Instantly...
Expansion adds more temperature-controlled storage and dedicated space for FastChain ® demand-led supply service Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansio...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...